Intelligent Bio Solutions Balance Sheet Health
Financial Health criteria checks 5/6
Intelligent Bio Solutions has a total shareholder equity of $3.2M and total debt of $601.5K, which brings its debt-to-equity ratio to 19.1%. Its total assets and total liabilities are $8.8M and $5.7M respectively.
Key information
19.1%
Debt to equity ratio
US$601.50k
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.12m |
| Equity | US$3.15m |
| Total liabilities | US$5.67m |
| Total assets | US$8.83m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: INBS's short term assets ($2.9M) do not cover its short term liabilities ($5.2M).
Long Term Liabilities: INBS's short term assets ($2.9M) exceed its long term liabilities ($489.7K).
Debt to Equity History and Analysis
Debt Level: INBS has more cash than its total debt.
Reducing Debt: INBS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: INBS has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: INBS is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.